NO173958C - Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus - Google Patents

Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus

Info

Publication number
NO173958C
NO173958C NO874740A NO874740A NO173958C NO 173958 C NO173958 C NO 173958C NO 874740 A NO874740 A NO 874740A NO 874740 A NO874740 A NO 874740A NO 173958 C NO173958 C NO 173958C
Authority
NO
Norway
Prior art keywords
antibody
procedure
hiv virus
detecting presence
polypeptides
Prior art date
Application number
NO874740A
Other languages
English (en)
Norwegian (no)
Other versions
NO874740L (no
NO874740D0 (no
NO173958B (no
Inventor
Wesley L Cosand
Linda J Harris
Raymond L Houghton
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NO874740D0 publication Critical patent/NO874740D0/no
Publication of NO874740L publication Critical patent/NO874740L/no
Publication of NO173958B publication Critical patent/NO173958B/no
Publication of NO173958C publication Critical patent/NO173958C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO874740A 1986-11-14 1987-11-13 Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus NO173958C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/930,785 US5075211A (en) 1986-03-26 1986-11-14 Synthetic antigen for the detection of AIDS-related disease

Publications (4)

Publication Number Publication Date
NO874740D0 NO874740D0 (no) 1987-11-13
NO874740L NO874740L (no) 1988-05-16
NO173958B NO173958B (no) 1993-11-15
NO173958C true NO173958C (no) 1994-02-23

Family

ID=25459766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874740A NO173958C (no) 1986-11-14 1987-11-13 Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus

Country Status (11)

Country Link
US (1) US5075211A (da)
EP (1) EP0267802B1 (da)
JP (1) JP2886861B2 (da)
AT (1) ATE163766T1 (da)
AU (1) AU616383B2 (da)
CA (1) CA1340097C (da)
DE (1) DE3752170T2 (da)
DK (1) DK174533B1 (da)
ES (1) ES2115584T3 (da)
IE (1) IE81132B1 (da)
NO (1) NO173958C (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273695B1 (en) * 1984-10-31 2007-09-25 Novartis Vaccines And Diagnostics, Inc. HIV immunoassays using synthetic envelope polypeptides
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
ZA896768B (en) * 1988-09-09 1990-06-27 Akzo Nv Synthetic polypeptides immunochemically reactive with hiv-antibodies
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
US6589734B1 (en) 1989-07-11 2003-07-08 Gen-Probe Incorporated Detection of HIV
WO1991001384A1 (en) * 1989-07-11 1991-02-07 Gen-Probe, Incorporated Nucleic acid sequence amplification methods utilizing a transcription complex
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
SE9101863D0 (sv) * 1991-06-13 1991-06-13 Replico Medical Ab Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
JPH06503843A (ja) * 1991-11-04 1994-04-28 デイド、インターナショナル、インコーポレイテッド Ｈｉｖ−２ウイルスの一部分に対応する合成ペプチドおよび改良されたイムノアッセイにおけるその使用方法
CA2102301C (en) * 1992-03-06 2008-09-16 Robert De Leys Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) * 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6632613B1 (en) * 1993-06-02 2003-10-14 University Of Utah Research Foundation Compositions and kits for fluorescence polarization assay of large molecules
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
EP0733063B1 (en) * 1993-12-09 2003-12-17 University of Utah Research Foundation Compositions and kits for fluorescence polarization assay of large molecules
AU753780B2 (en) * 1997-08-01 2002-10-31 Bio-Rad Laboratories, Inc. Synthetic antigen for the detection of antibodies immunoreactive with HIV virus
GB9717652D0 (en) * 1997-08-20 1997-10-22 Nycomed Imaging As Method
US6656471B1 (en) 1998-11-17 2003-12-02 Board Of Regents, The University Of Texas System HIV-specific T-cell induction
US6623920B1 (en) * 1999-07-09 2003-09-23 Gen-Probe Incorporated Detection of HIV-1 by nucleic acid amplification
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
KR101933685B1 (ko) * 2018-06-29 2018-12-28 주식회사 에스알바이오텍 약물이 코팅된 마이크로 니들 및 이의 제조방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
CA1341620C (en) * 1984-10-18 2011-08-23 Luc Montagnier Envelope antigens of hiv-1
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
JPS61233700A (ja) * 1984-12-24 1986-10-17 ジエネンテク，インコ−ポレイテツド 分子クロ−ンされたエイズ関連ポリペプチド
EP0220234B1 (en) * 1985-04-08 1994-08-03 Genetic Systems Corporation EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
EP0220273B2 (en) * 1985-04-29 2007-01-17 Bio-Rad Laboratories, Inc. Synthetic antigens for the detection of aids-related disease
US4661445A (en) * 1985-05-24 1987-04-28 Saxinger W Carl Competitive ELISA for the detection of HTLV-III antibodies
US4704357A (en) * 1985-09-30 1987-11-03 United States Of America As Represented By The Department Of Health And Human Services Immortalized T-lymphocyte cell line for testing HTLV-III inactivation
CS256960B1 (en) * 1985-11-16 1988-04-15 Viktor Krchnak Peptides with properties of antigenic determinants and method of their production
NO870027L (no) * 1986-01-06 1987-07-07 Hoffmann La Roche Ekspresjon av htlv-iii gag-gen.
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
WO1987007296A1 (en) * 1986-05-20 1987-12-03 The Trustees Of Columbia University In The City Of Expression of human t-cell lymphotropic virus (htlv-iii) reverse transcriptase and uses thereof

Also Published As

Publication number Publication date
CA1340097C (en) 1998-10-20
DK597787A (da) 1988-05-15
DE3752170T2 (de) 1998-10-08
IE873073L (en) 1988-05-14
NO874740L (no) 1988-05-16
IE81132B1 (en) 2000-03-22
JPS63221247A (ja) 1988-09-14
DK597787D0 (da) 1987-11-13
EP0267802B1 (en) 1998-03-04
US5075211A (en) 1991-12-24
EP0267802A2 (en) 1988-05-18
DE3752170D1 (de) 1998-04-09
DK174533B1 (da) 2003-05-12
JP2886861B2 (ja) 1999-04-26
ATE163766T1 (de) 1998-03-15
AU8121187A (en) 1988-05-19
ES2115584T3 (es) 1998-07-01
NO874740D0 (no) 1987-11-13
EP0267802A3 (en) 1991-03-06
AU616383B2 (en) 1991-10-31
NO173958B (no) 1993-11-15

Similar Documents

Publication Publication Date Title
NO173958C (no) Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus
EP0220273A4 (en) SYNTHETIC ANTIGENS TO DETECT AIDS.
ES8708058A1 (es) Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii
DE3876496D1 (de) Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
IE940558L (en) Process for purifying recombinant proteins, and use of¹products thereof
BR9305435A (pt) Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos
AU637097B2 (en) Process for preparing an improved western blot immunoassay
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
EP0201716A3 (en) Expression of immunologically reactive viral proteins
FI901791A7 (fi) Lymfosyyttien reaktivisuuden määrittäminen veressä olevien spesifistenantigeenien suhteen
EP0317804A3 (en) Hiv peptides and methods for detection of hiv
ATE467690T1 (de) Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
FI885868A7 (fi) Menetelmä immuunikatoviruksen vasta-aineiden havaitsemiseksi
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE70979T1 (de) Plasmodium-falciparum-antigene der intraerythrocytaeren phase, ihre reinigung sowie antigen- und antikoerperbestimmung und sie enthaltende malaria-impfstoffe.
FI870500A7 (fi) Reagenssi virus-antigeenin vasta-aineen määrittämiseksi.

Legal Events

Date Code Title Description
MK1K Patent expired